Micregen Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.21M

  • Investors
  • 2

Micregen General Information

Description

Developer of a stem cell secretome technology designed to guide cells toward producing ready-to-use therapeutic secretions for addressing degenerative and developmental conditions. The company's platform offers proprietary secretome formulations, scalable cell-free manufacturing, and immune-compatible sourcing, enabling clinicians and patients within regenerative medicine to promote tissue repair and functional recovery.

Contact Information

Website
www.micregen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Gateway, 1 Collegiate Square
  • Thames Valley Science Park, Berkshire
  • Reading RG2 9LH
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • The Gateway, 1 Collegiate Square
  • Thames Valley Science Park, Berkshire
  • Reading RG2 9LH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micregen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 05-Apr-2021 $7.21M Completed Clinical Trials - Phase 1
4. Angel (individual) 25-May-2018 Completed Clinical Trials - Phase 1
3. Grant 01-Jan-2018 Completed Clinical Trials - Phase 1
2. Angel (individual) 01-Apr-2017 $2.23M $3.67M Completed Clinical Trials - Phase 1
1. Angel (individual) 28-Sep-2016 $1.43M $1.43M Completed Startup
To view Micregen’s complete valuation and funding history, request access »

Micregen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C Ordinary
C Ordinary
C Ordinary 493,288 $0.000017 $5.07 $5.07 1x $5.07 4.57%
C Ordinary 454,167 $0.000017 $3.32 $3.32 1x $3.32 4.21%
To view Micregen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Micregen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a stem cell secretome technology designed to guide cells toward producing ready-to-use therapeutic secretio
Drug Discovery
Reading, United Kingdom
10 As of 2025

Redwood City, CA
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Micregen Competitors (6)

One of Micregen’s 6 competitors is Juvena Therapeutics, a Venture Capital-Backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Juvena Therapeutics Venture Capital-Backed Redwood City, CA
Noveome Biotherapeutics Venture Capital-Backed Pittsburgh, PA
Immunis Venture Capital-Backed Irvine, CA
Mesoblast Corporation Melbourne, Australia
ReNeuron Group Formerly VC-backed Bridgend, United Kingdom
To view Micregen’s complete competitors history, request access »

Micregen Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Micregen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202318831-D0 Immortalised stem cells and therapeutic products thereof Inactive 11-Dec-2023
GB-202106953-D0 Immortalised stem cells and therapeutic products thereof Inactive 14-May-2021

Micregen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micregen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pitalia Capital Family Office Minority
Innovate UK Government
To view Micregen’s complete investors history, request access »

Ready to get started?

Request a free trial

Micregen Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Mrg1161 Bolton, United Kingdom 2019

Micregen FAQs

  • When was Micregen founded?

    Micregen was founded in 2015.

  • Where is Micregen headquartered?

    Micregen is headquartered in Reading, United Kingdom.

  • What is the size of Micregen?

    Micregen has 10 total employees.

  • What industry is Micregen in?

    Micregen’s primary industry is Drug Discovery.

  • Is Micregen a private or public company?

    Micregen is a Private company.

  • What is the current valuation of Micregen?

    The current valuation of Micregen is .

  • What is Micregen’s current revenue?

    The current revenue for Micregen is .

  • How much funding has Micregen raised over time?

    Micregen has raised $12.2M.

  • Who are Micregen’s investors?

    Pitalia Capital and Innovate UK have invested in Micregen.

  • Who are Micregen’s competitors?

    Juvena Therapeutics, Noveome Biotherapeutics, Immunis, Mesoblast, and ReNeuron Group are some of the 6 competitors of Micregen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process